DIN 02553295 — APO-CLADRIBINE 10 MG
APO-CLADRIBINE is a tablet of Cladribine marketed by APOTEX INC. The full Cladribine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02553295
- Brand name
- APO-CLADRIBINE
- Active ingredient
- Cladribine
- Strength
- 10 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- APOTEX INC
- Health Canada status
- MARKETED
- Drug class
- Selective immunosuppressant (purine nucleoside analogue)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Cladribine products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02566443 | AURO-CLADRIBINE | 10 MG | TABLET | AURO PHARMA INC | MARKETED |
| 02319918 | CLADRIBINE INJECTION | 1 MG | SOLUTION | FRESENIUS KABI CANADA LTD | MARKETED |
| 02494574 | CLADRIBINE INJECTION | 1 MG | SOLUTION | GENERIC MEDICAL PARTNERS INC | MARKETED |
| 02470179 | MAVENCLAD | 10 MG | TABLET | EMD SERONO, A DIVISION OF EMD INC., CANADA | MARKETED |